Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELATACEPT for Transplant rejection: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 34 adverse event reports in the FDA FAERS database where BELATACEPT was used for Transplant rejection.

Most Reported Side Effects for BELATACEPT

Side Effect Reports % Deaths Hosp.
Off label use 304 8.9% 42 124
Death 206 6.0% 206 16
Transplant rejection 178 5.2% 18 66
Cytomegalovirus infection 142 4.2% 27 55
Drug ineffective 142 4.2% 17 49
Product storage error 142 4.2% 1 4
Acute kidney injury 137 4.0% 27 96
Covid-19 129 3.8% 30 86
Hospitalisation 123 3.6% 0 123
Kidney transplant rejection 97 2.8% 10 45
Intentional product use issue 83 2.4% 4 20
Post transplant lymphoproliferative disorder 82 2.4% 39 50
Product preparation error 80 2.4% 0 0
Pyrexia 77 2.3% 7 59
Pneumocystis jirovecii pneumonia 75 2.2% 21 33

Other Indications for BELATACEPT

Renal transplant (1,132) Product used for unknown indication (1,047) Immunosuppressant drug therapy (509) Prophylaxis against transplant rejection (259) Immunosuppression (255) Lung transplant (91) Heart transplant (35) Transplant (27) Kidney transplant rejection (23) Prophylaxis (18)

Other Drugs Used for Transplant rejection

METHYLPREDNISOLONE (968) RITUXIMAB (615) TACROLIMUS (477) HUMAN IMMUNOGLOBULIN G (327) PREDNISONE (300) MYCOPHENOLATE MOFETIL (297) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (273) ECULIZUMAB (176) THYMOCYTE IMMUNE GLOBULIN NOS (173) BORTEZOMIB (145)

Related Pages

BELATACEPT Full Profile All Transplant rejection Drugs BELATACEPT Demographics BELATACEPT Timeline